title: Eplerenone relieves spironolactone-induced painful gynaecomastia in a patient with primary aldosteronism.
authors.forename: Asterios
authors.initials: A
authors.lastname: Karagiannis
authors.forename: Konstantinos
authors.initials: K
authors.lastname: Tziomalos
authors.forename: Anna
authors.initials: A
authors.lastname: Kakafika
authors.forename: Matilda
authors.initials: M
authors.lastname: Florentin
authors.forename: Vassilios Gabriel
authors.initials: VG
authors.lastname: Athyros
mesh_terms: D000284:Administration, Oral; D000450:Aldosterone / Q000097:blood; D002986:Clinical Trials as Topic; D000077545:Eplerenone; D006177:Gynecomastia / Q000139:chemically induced / Q000188:drug therapy*; D006801:Humans; D006929:Hyperaldosteronism / Q000628:therapy*; D006973:Hypertension / Q000628:therapy; D008297:Male; D008875:Middle Aged; D000451:Mineralocorticoid Receptor Antagonists; D012083:Renin / Q000097:blood; D012737:Sex Factors; D013148:Spironolactone / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000378:metabolism / Q000494:pharmacology*
chemical_list: D000451:Mineralocorticoid Receptor Antagonists; D013148:Spironolactone; D000450:Aldosterone; D000077545:Eplerenone; D012083:Renin